IView-1201 Phase II IND application for the Treatment of Adenoviral Conjunctivitis Accepted by US FDA
IView-1201 Phase II IND application for the Treatment of Adenoviral Conjunctivitis Accepted by US FDA
Comments are closed.
IView-1201 Phase II IND application for the Treatment of Adenoviral Conjunctivitis Accepted by US FDA